Skip to content

The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery

The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery.

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01579175
Acronym
GumGyn
Enrollment
294
Registered
2012-04-17
Start date
2010-01-31
Completion date
2013-02-28
Last updated
2013-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Ileus

Brief summary

The investigators are randomizing patients to receive chewing gum (Extra Sugar Free, Spearment) every 4 hours during waking hours for 15 minutes versus standard postoperative care. The investigators then have them fill out a survey in house and 1 week after their surgery that record time to first flatus, hunger, toleration of clear liquids and food and some information about pain, satisfaction, and quality of life. The investigators contact them via phone and email a maximum of three times in order to collect this information. 30 days postoperatively the investigators also contact them and perform a chart review for any postoperative complications.

Interventions

OTHERChewing gum

Sugar Free (Extra spearment) gum given to chew every 4 hours during waking hours for 15 minutes.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * Undergoing benign gynecologic surgery via an exploratory laparotomy * Capable of giving consent

Exclusion criteria

* Oromaxillary or mental disturbances that would make chewing gum dangerous with regards to mastication or aspiration * Intubated or unconscious when leaving the OR * Bowel resection performed at the time of surgery * Active bowel disease (IBD, appendicitis, etc) * Gynecologic malignancy

Design outcomes

Primary

MeasureTime frame
Time to flatus30 days

Secondary

MeasureTime frameDescription
Postoperative ileus30 daysNausea, vomiting, abdominal distention two episodes of 100cc of emesis
time to discharge30 days
time to toleration of diet30 days
patient satisfaction30 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026